Nephropathic Cystinosis: Clinical Trials

7 trials for Nephropathic Cystinosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1
Not applicable1Completed 1
Phase 11Recruiting 1

Follow Nephropathic Cystinosis: new trials by email Literature Review of Nephropathic Cystinosis trials Research Report on Nephropathic Cystinosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pilot Study of TTI-0102 in Cystinosis
TTI-0102 (cysteamine-pantetheine disulfide) - Nephropathic Cystinosis, Cystinosis
Phase 2Not yet recruitingThiogenesis Therapeutics, Inc.62026-10-012026-09-23
DFT383 in Pediatric Participants With Nephropathic Cystinosis
DFT383 - Nephropathic Cystinosis
Phase 1 / Phase 2RecruitingNovartis Pharmaceuticals302025-06-022026-10-16
Observational Study to Assess the Quality of Life in Nephropathic Cystinosis Patients
Cysteamine Bitartrate - Nephropathic Cystinosis
UnknownChiesi SA/NV312020-07-312021-11-29
CYSTEA-BONE Clinical Study
Blood sampling - Nephropathic Cystinosis
CompletedHospices Civils de Lyon422019-04-052026-10-22
Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™
Cysteamine bitartrate - Cystinosis, Nephropathic Cystinosis
Not applicableCompletedUniversity of California, San Diego82011-09-012013-10-09
Cure Cystinosis International Registry
Cystinosis, Nephropathic Cystinosis
UnknownCystinosis Research Foundation7502010-08-012014-03-12
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Rare Disorders, Undiagnosed Disorders
RecruitingSanford Health200002010-07-012026-10-28

Narrower conditions

Cystinosis (7)  ·  Fanconi Syndrome (2)  ·  Lysosomal Storage Diseases (2)  ·  Rare Diseases (2)  ·  3-Methylglutaconic Aciduria, Type V (1)  ·  Achalasia Addisonianism Alacrimia syndrome (1)  ·  Acrodysostosis (1)  ·  Activated PI3K-delta Syndrome (1)  ·  Addison Disease (1)  ·  Alagille Syndrome (1)  ·  Alstrom Syndrome (1)  ·  Amnesia, Transient Global (1)  ·  Aniridia (1)  ·  Aniridia and Absent Patella (1)  ·  Aniridia, Partial, with Unilateral Renal Agenesis and Psychomotor Retardation (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7)  ·  Genetic Diseases, Inborn (7)  ·  Nutritional and Metabolic Diseases (7)  ·  Metabolic Diseases (6)  ·  Metabolism, Inborn Errors (6)  ·  Lysosomal Storage Diseases (5)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Renal Tubular Transport, Inborn Errors (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Disease Attributes (2)  ·  Pathologic Processes (2)

Interventions

Cysteamine (2)  ·  Blood Specimen Collection (1)  ·  cysteamine-pantetheine disulfide (1)

Sponsors

Chiesi SA/NV (1)  ·  Cystinosis Research Foundation (1)  ·  Hospices Civils de Lyon (1)  ·  Novartis Pharmaceuticals (1)  ·  Sanford Health (1)  ·  Thiogenesis Therapeutics, Inc. (1)  ·  University of California, San Diego (1)

Countries

United States (4)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Turkey (Türkiye) (1)

Top investigators

Jerry A Schneider, M.D. (1)  ·  Laurence A Greenbaum, MD, PhD, FAAP (1)  ·  Patrice P Rioux, MD, PhD (1)  ·  Ranjan Dohil, M.D. (1)

Results publications

PMID 20716238, PMID 22205430